✦ LIBER ✦

High prevalence of BRCA1 founder mutations in Greek breast/ovarian families

✍ Scribed by Konstantopoulou, I; Tsitlaidou, M; Fostira, F; Pertesi, M; Stavropoulou, A-V; Triantafyllidou, O; Tsotra, E; Tsiftsoglou, AP; Tsionou, C; Droufakou, S; Dimitrakakis, C; Fountzilas, G; Yannoukakos, D

Book ID: 121260555
Publisher: John Wiley and Sons
Year: 2013
Tongue: English
Weight: 650 KB
Volume: 85
Category: Article
ISSN: 0009-9163
DOI: 10.1111/cge.12274

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Founder BRCA1 and BRCA2 Mutations in Fre

Founder BRCA1 and BRCA2 Mutations in French Canadian Breast and Ovarian Cancer Families

✍ Patricia N. Tonin; Anne-Marie Mes-Masson; P. Andrew Futreal; Kenneth Morgan; Mic 📂 Article 📅 1998 🏛 American Society of Human Genetics 🌐 English ⚖ 439 KB

Founder Mutations in the BRCA1 Gene in P

Founder Mutations in the BRCA1 Gene in Polish Families with Breast-Ovarian Cancer

✍ B. Górski; T. Byrski; T. Huzarski; A. Jakubowska; J. Menkiszak; J. Gronwald; A. 📂 Article 📅 2000 🏛 American Society of Human Genetics 🌐 English ⚖ 117 KB

A high proportion of founder BRCA1 mutat

A high proportion of founder BRCA1 mutations in Polish breast cancer families

✍ Bohdan Górski; Anna Jakubowska; Tomasz Huzarski; Tomasz Byrski; Jacek Gronwald; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 71 KB 👁 1 views

## Abstract Three mutations in __BRCA1__ (5382insC, C61G and 4153delA) are common in Poland and account for the majority of mutations identified to date in Polish breast and breast–ovarian cancer families. It is not known, however, to what extent these 3 founder mutations account for all of the BRC

Prevalence of founder BRCA1 and BRCA2 mu

Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in hungary

✍ Marco Van der Looij; Csilla Szabo; Istvan Besznyak; Gyorgy Liszka; Bela Csokay; 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 55 KB 👁 2 views

We have investigated the impact of BRACA1 and BRACA2 mutations that were frequently identified among Hungarian high-risk breast-ovarian cancer families (Ramus et al., 1997b, AJHG), on the development of breast and ovarian cancer in the general Hungarian population. The prevalence of 3 BRCA1 mutation

Prevalence of BRCA Mutations and Founder

Prevalence of BRCA Mutations and Founder Effect in High-Risk Hispanic Families

✍ Weitzel, J. N. 📂 Article 📅 2005 🏛 American Association for Cancer Research 🌐 English ⚖ 157 KB

A low frequency of non-founder BRCA1 mut

A low frequency of non-founder BRCA1 mutations in Ashkenazi Jewish breast–ovarian cancer families

✍ Catherine M. Phelan; Elaine Kwan; Elaine Jack; Song Li; Cindy Morgan; Jennifer A 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 1 views

The 185delAG and 5382insC founder mutations account for the majority of mutations identified in BRCA1 in Ashkenazi Jewish breast and breast-ovarian cancer families. Few non-founder BRCA1 mutations have been identified to date in these families. We initially screened a panel of 245 Ashkenazi Jewish b